Most of us treat precharting as a quality-of-care chore—a quick scan of labs, specialist notes, and the last visit before walking into the exam room. The CMS 2027 Medicare Advantage rule changes the stakes entirely. Starting in 2027, MA plans can no longer rely on retrospective chart reviews to capture diagnoses missed during the encounter. Diagnostic capture has to happen prospectively, in the room, in real time.
That shifts a lot of weight onto the few minutes before each visit. Every chronic condition, lab trend, and specialist update we fail to surface in the prep doesn't just affect the visit—it affects the risk-adjusted payment.
So how do you preround a full panel without spending an hour on chart synthesis, and still catch what now drives both clinical outcomes and revenue?
